You are here: Industry Insights > COVID-19

News List

Calquence showed promising clinical improvement in majority of 19 hospitalised COVID-19 patients worldpharmanews
June 08, 2020
Results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor, reduced markers of inflammation and improved clinical outcomes of patients with severe COVID-19 disease.(1)
Cellenkos Announces FDA Clearance for Trial of CK0802 for COVID-19 ARDS americanpharmaceuticalreview
June 08, 2020
Cellenkos announced the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for treatment of COVID-19 associated acute respiratory distress syndrome.
Qualigen Releases FastPack? SARS-CoV-2 Antibody Diagnostic Test americanpharmaceuticalreview
June 08, 2020
Qualigen Therapeutics has released a pre-launch supply of its proposed FastPack? SARS-CoV-2 IgG Immunoassay diagnostic test kits to the University of Louisville to conduct validation studies ...
Clinical Ink Implements COVID-19 Therapy Trial americanpharmaceuticalreview
June 08, 2020
Clinical Ink has helped expedite the study of a treatment for cytokine storm, the immunological reaction associated with severe cases of COVID-19.
Australia’s CSL says to help fund, make vaccine candidate if it proves successful expresspharma
June 08, 2020
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the virus, CSL said.
Sun Pharma initiates Phase II clinical trial on AQCH as potential treatment for COVID-19 expresspharma
June 08, 2020
AQCH is the first phytopharmaceutical drug approved for clinical trial by DCGI for COVID-19 and has shown anti-SARS-CoV-2 effects in in-vitro studies.
Anti-TNF therapies could treat patients with COVID-19-related ARDS expresspharma
June 08, 2020
This would reduce COVID-19 mortality, as about 17 of COVID-19 patients develop ARDS, states GlobalData.
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage: GlobalData expresspharma
June 08, 2020
The advantages will be in terms of supply and price for the formulations manufactured in India, be it remdesivir, favipiravir or hydroxychloroquine (HCQ).
The COVID-19 effect on pharma packaging expresspharma
June 08, 2020
Experts share insights on how COVID-19 is likely to alter trends in pharma packaging and determine its future progress.
Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope expresspharma
June 08, 2020
Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are also caused by corona virus, tweeted Tope.